van der Linden and other members of the Dutch Bone Metastasis Study Group developed a score for predicting survival in patients with metastases to the spinal column. The authors are from multiple university medical centers in The Netherlands.
Parameters:
(1) Karnofsky performance scale (KPS)
(2) site of primary tumor
(3) visceral metastasis
Parameter |
Finding |
Points |
---|---|---|
Karnofsky performance scale |
80 to 100 (good) |
2 |
|
50 to 70 (fair) |
1 |
|
20 to 40 (poor) |
0 |
site of primary tumor |
breast |
3 |
|
prostate |
2 |
|
lung |
1 |
|
other |
0 |
visceral metastases |
absent |
1 |
|
present |
0 |
total score =
= SUM(points for all 3 parameters)
Interpretation:
• minimum score: 0
• maximum score: 6
• The higher the score the better the prognosis.
Score |
Group |
Median Survival |
Probability of 2 Year Survival |
---|---|---|---|
<= 3 |
A |
3 months |
about 4% |
4 or 5 |
B |
9 months |
22% |
6 |
C |
19 months |
37% |
estimated from Figure 2, page 326
Purpose: To evaluate a patient with metastatic cancer to the spine using the prognostic score of van der Linden et al from the Dutch Bone Marrow Metastasis Study Group.
Specialty: Hematology Oncology, Surgery, general
Objective: risk factors, severity, prognosis, stage
ICD-10: C79.9,